帥心濤、魏波教授團隊在Journal of Controlled release上發表最新研究成果
中大新聞網訊(通訊員丁東兵)近期,附屬第三醫院帥心濤、魏波教授團隊在藥劑學領域國際頂級學術期刊《Journal of Controlled release》(IF=10.8)上發表題為“Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer”的原創性研究成果。結腸癌的發病率目前仍呈上升趨勢,是常見的消化道惡性腫瘤之一。肝轉移是結腸癌最常見...